Sun Pharma – Express Pharma

Sun Pharma arm settles case with Biofrontera, to get $22.5 million

Sun Pharma recalls over 1.10 lakh bottles of generic drug in US market

Sun Pharma to introduce Molnupiravir licensed from MSD and Ridgeback

Sun Pharma launches acnce treatment cream in US

Docmode breaks COVID-induced barrier with Gapsule

Sun Pharma and Cassiopea announce expiry of HSR Act process and consummation of Winlevi agreement

Sun Pharma and Cassiopea SpA sign license and supply agreements for Winlevi

Biocon Q1FY22 revenue at Rs 1,808 crores, up six per cent

Sun Pharma launches ‘Sunkalp’ on the occasion of National Doctors’ Day

Sun Pharma announces settlement of patent litigation for generic Revlimid in the US